ZACCHIA, Miriam
 Distribuzione geografica
Continente #
EU - Europa 6.130
AS - Asia 2.516
NA - Nord America 2.000
SA - Sud America 496
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 11.193
Nazione #
RU - Federazione Russa 4.039
US - Stati Uniti d'America 1.967
SG - Singapore 765
IT - Italia 594
HK - Hong Kong 586
IE - Irlanda 580
CN - Cina 527
BR - Brasile 416
GB - Regno Unito 256
IN - India 205
DE - Germania 170
UA - Ucraina 154
VN - Vietnam 140
KR - Corea 133
FR - Francia 61
SE - Svezia 58
FI - Finlandia 46
GR - Grecia 42
AR - Argentina 37
AT - Austria 35
TR - Turchia 32
AE - Emirati Arabi Uniti 25
JP - Giappone 24
ES - Italia 21
BD - Bangladesh 20
BE - Belgio 19
NL - Olanda 19
CA - Canada 17
IQ - Iraq 13
EC - Ecuador 12
ID - Indonesia 12
EG - Egitto 11
MX - Messico 11
UZ - Uzbekistan 11
ZA - Sudafrica 10
DK - Danimarca 9
CO - Colombia 7
HU - Ungheria 7
PL - Polonia 6
CL - Cile 5
MA - Marocco 5
PE - Perù 5
PK - Pakistan 5
PY - Paraguay 5
TN - Tunisia 5
CZ - Repubblica Ceca 4
EU - Europa 4
KE - Kenya 4
PH - Filippine 4
UY - Uruguay 4
VE - Venezuela 4
NO - Norvegia 3
AO - Angola 2
AU - Australia 2
AZ - Azerbaigian 2
DZ - Algeria 2
HN - Honduras 2
IR - Iran 2
KG - Kirghizistan 2
MK - Macedonia 2
A1 - Anonimo 1
AL - Albania 1
BT - Bhutan 1
CG - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GI - Gibilterra 1
GY - Guiana 1
JM - Giamaica 1
KW - Kuwait 1
LT - Lituania 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 11.193
Città #
Moscow 1.468
Hong Kong 586
Dublin 574
Santa Clara 333
Singapore 312
Chandler 263
Jacksonville 250
Bengaluru 185
Seoul 133
Hefei 127
Beijing 91
Chicago 83
London 82
Naples 82
Bremen 76
Princeton 73
Roxbury 69
Ashburn 67
Ann Arbor 66
New York 57
Ho Chi Minh City 54
Medford 49
Caserta 45
Aversa 31
Dallas 30
Hanoi 30
Woodbridge 29
Cambridge 28
Nuremberg 27
Des Moines 26
Napoli 24
São Paulo 24
Boardman 23
Wilmington 21
Vienna 20
Rome 19
The Dalles 19
Los Angeles 16
Brussels 15
Madrid 15
Milan 15
Belo Horizonte 13
Jinan 12
Salvador 11
San Mateo 11
Amsterdam 10
Casoria 10
Tashkent 10
Ariano Irpino 9
Tianjin 9
Zhengzhou 9
Auburn Hills 8
Baghdad 8
Brasília 8
Changsha 8
Da Nang 8
Ercolano 8
Falkenstein 8
Mountain View 8
Rho 8
Volla 8
Aarhus 7
Atlanta 7
Cairo 7
Curitiba 7
Düsseldorf 7
Frankfurt am Main 7
Nanjing 7
Brooklyn 6
Dhaka 6
Dundalk 6
Guayaquil 6
Lappeenranta 6
Munich 6
Ningbo 6
Pelotas 6
San Francisco 6
Guangzhou 5
Haiphong 5
Hangzhou 5
Hebei 5
Nanchang 5
Porto Alegre 5
Redwood City 5
Thái Bình 5
Turku 5
Arzano 4
Bari 4
Can Tho 4
Chennai 4
Contagem 4
Elora 4
Fortaleza 4
Guarulhos 4
Haikou 4
Istanbul 4
Jaboatão dos Guararapes 4
Lima 4
Marcianise 4
Montevideo 4
Totale 5.925
Nome #
Rare Renal Diseases Can Be Used as Tools to Investigate Common Kidney Disorders 244
Acid-base transport in Henle's loop: The effects of reduced renal mass and diabetes 205
MicroRNAs in Renal Diseases: A Potential Novel Therapeutic Target 182
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 180
Big databases and biobanks for studying the links between CKD, cognitive impairment, and dementia 177
ADAM17, a New Player in the Pathogenesis of Chronic Kidney Disease–Mineral and Bone Disorder 173
Bartter syndrome 169
Application of proteomics and metabolomics to study inherited kidney disorders: from big data to precision medicine 162
A case of valproic acid-induced acute pancreatitis in tuberous sclerosis coexisting with end-stage renal disease 160
A fate-mapping approach reveals the composite origin of the connecting tubule and alerts on “single-cell”-specific KO model of the distal nephron 159
A case series of adult patients affected by EAST/SeSAME syndrome suggests more severe disease in subjects bearing KCNJ10 truncating mutations 158
Cognitive impairment in CKD patients: a guidance document by the CONNECT network 153
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis 153
Renal phenotype in bardet-biedl syndrome: A combined defect of urinary concentration and dilution is associated with defective urinary aqp2 and umod excretion 152
Genetic characterization of Italian patients with Bardet-Biedl syndrome and correlation to ocular, renal and audio-vestibular phenotype: Identification of eleven novel pathogenic sequence variants 152
miRNA-23a modulates sodium-hydrogen exchanger 1 expression: studies in medullary thick ascending limb of salt induced hypertensive rats 151
Bilancio glomerulo tubulare del diabete mellito:evidenze molecolari e conseguenze cliniche 149
Divergent behavior of hydrogen sulfide pools and of the sulfur metabolite lanthionine, a novel uremic toxin, in dialysis patients 148
The Sulfur Metabolite Lanthionine: Evidence for a Role as a Novel Uremic Toxin 144
A Controversial Case of a Double Hepatic Incidentaloma in a Male Patient with Kidney Failure 144
Bardet-Biedl Syndrome: Current Perspectives and Clinical Outlook 143
Metabolomic fingerprinting of renal disease progression in Bardet-Biedl syndrome reveals mitochondrial dysfunction in kidney tubular cells. 142
Diuretic Resistance in Cardio-Nephrology: Role of Pharmacokinetics, Hypochloremia, and Kidney Remodeling 142
Nephroplex: a kidney-focused NGS panel highlights the challenges of PKD1 sequencing and identifies a founder BBS4 mutation 142
Looking beyond Entecavir to discover Gitelman Syndrome in a 50 year-old man 141
Acute and chronic effects of metabolic acidosis on renal function and structure 140
Acid regulation of NaDC-1 requires a functional endothelin B receptor. 139
Delay in Renal Hemodynamic Response to a Meat Meal in Severe Obesity 138
Uremic Toxin Lanthionine Interferes with the Transsulfuration Pathway, Angiogenetic Signaling and Increases Intracellular Calcium 138
Lanthionine and Other Relevant Sulfur Amino Acid Metabolites: Detection of Prospective Uremic Toxins in Serum by Multiple Reaction Monitoring Tandem Mass Spectrometry 138
Acid stimulation of the citrate transporter NaDC-1 requires Pyk2 and ERK1/2 signaling pathways 137
Characterization of five novel vasopressin V2 receptor mutants causing nephrogenic diabetes insipidus reveals a role of tolvaptan for M272R-V2R mutation 137
Bardet–Biedl syndrome: The pleiotropic role of the chaperonin-like BBS6, 10, and 12 proteins 136
Nephrotic syndrome: new concepts in the pathophysiology of sodium retention 134
Channels, carriers, and pumps in the pathogenesis of sodium-sensitive hypertension 133
L’idrossitirosolo protegge dallo stress ossidativo indotto dalla ciclosporina A, ma non dall’alterazione dei parametri emodinamici 133
Cyclosporin-induced hypertension is associated with the up-regulation of Na+-K+-2Cl- cotransporter (NKCC2) 129
Potassium: From Physiology to Clinical Implications 129
Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria 128
Translational research on cognitive impairment in chronic kidney disease 127
Physiopathology of Potassium Deficiency 127
Molecular mechanisms in sodium dependent hypertension 126
Impact of Local and Systemic Factors on Kidney Dysfunction in Bardet-Biedl Syndrome 126
L’IDROSSITIROSOLO PROTEGGE DALLO STRESS OSSIDATIVI INDOTTO DALLA CICLOSPORINA A, MA NON DALL’ALTERAZIONE DEI PARAMETRI EMODINAMICI 125
The SGLT2 inhibitor dapagliflozin improves kidney function in glycogen storage disease XI 123
Urine Proteomics Revealed a Significant Correlation Between Urine-Fibronectin Abundance and Estimated-GFR Decline in Patients with Bardet-Biedl Syndrome 122
Hypertension and renal calcium transport 119
Renal Cystinuria and Immune Cells (T Lymphocytes) Dysfunction: What We Know about? 117
The role of the kidney in salt-sensitive hypertension 117
Brain dysfunction in tubular and tubulointerstitial kidney diseases 116
Urine concentrating defect as presenting sign of progressive renal failure in Bardet-Biedl syndrome patients 116
Ruolo delle acquaporine nei disordini del bilancio idro-salino 115
Computational and Structural Analysis to Assess the Pathogenicity of Bardet-Biedl Syndrome Related Missense Variants Identified in Bardet-Biedl Syndrome 10 Gene (BBS10) 113
Dehydration: a new modulator of klotho expression 111
GENOMICA FUNZIONALE 111
The Kidney in Bardet-Biedl Syndrome: Possible Pathogenesis of Urine Concentrating Defect 109
CKD in Bardet-Biedl Syndrome: Evidence Supporting Multifactorial Etiology 108
LA IPERFILTRAZIONE GLOMERULARE CARATTERISTICA DELLE FASI PRECOCI DEL DIABETE È LEGATA AD UNA ATTIVAZIONE DEL MECCANISMO DI FEED-BACK TUBULO GLOMERULARE 107
Exploring Key Challenges of Understanding the Pathogenesis of Kidney Disease in Bardet–Biedl Syndrome 107
Genomica funzionale 106
Upregulation of apical sodium-chloride cotransporter and basolateral chloride channels is responsible for the maintenance of salt-sensitive hypertension 105
The importance of uromodulin as regulator of salt reabsorption along the thick ascending limb 103
La iperfiltrazione glomerulare caratteristica delle fasi precoci del diabete è legata ad una attivazione del meccanismo di feed-back tubulo glomerulare 103
Renal handling of uric acid 101
Chemotherapy-related cognitive impairment and kidney dysfunction 100
Genomic and proteomic approaches to renal cell carcinoma 100
L’ipertensione indotta dalla ciclosporina è legata ad una attivazione del co-traporto Na-K-2Cl 100
Patho-physiology of renal dysfunction in Bardet-Biedl Syndrome 100
Guidelines for Genetic Testing and Management of Alport Syndrome 100
The Physiology of the Loop of Henle 99
ERK1,2 signalling pathway along the nephron and its role in acid-base and electrolytes balance 99
Parvalbumin: A key protein in early distal tubule NaCl reabsorption 98
L’IPERTENSIONE INDOTTA DALLA CICLOSPORINA È LEGATA AD UNA ATTIVAZIONE DEL CO-TRAPORTO NA-K-2CL 98
Urinary metabolic profile of patients with transfusion-dependent β-thalassemia major undergoing deferasirox therapy 96
Integration of Proteomics and Metabolomics in Exploring Genetic and Rare Metabolic Diseases 95
Clinical Practice Recommendations on Kidney Management in Methylmalonic Acidemia: an Expert Consensus Statement From ERKNet and MetabERN 94
Diffusion tensor imaging for the study of early renal dysfunction in patients affected by bardet-biedl syndrome 94
The importance of the thick ascending limb of Henle's loop in renal physiology and pathophysiology 93
The renal lesions in Bardet-Biedl Syndrome: history before and after the discovery of BBS genes 92
The academy of ideas 91
Bardet-Biedl syndrome improved diagnosis criteria and management: Inter European Reference Networks consensus statement and recommendations 91
Zebrafish, a novel model system to study uremic toxins: The case for the sulfur amino acid lanthionine 90
Urinary proteomics reveals key markers of salt sensitivity in hypertensive patients during saline infusion 90
Multi-Omics Studies Unveil Extraciliary Functions of BBS10 and Show Metabolic Aberrations Underlying Renal Disease in Bardet–Biedl Syndrome 88
Urinary proteome in inherited nephrolithiasis 87
Genome-Based Advances in Modelling Renal Ciliopathies and Enhancing Patient Care 86
Vitamin-D status and mineral metabolism in two ethnic populations with sarcoidosis 86
Proteomics and metabolomics studies exploring the pathophysiology of renal dysfunction in autosomal dominant polycystic kidney disease and other ciliopathies 81
The role of the intestinal microbiota in uremic solute accumulation: a focus on sulfur compounds 80
Next-Generation Sequencing (NGS) Analysis Illustrates the Phenotypic Variability of Collagen Type IV Nephropathies 79
Treatment and long-term outcome in primary nephrogenic diabetes insipidus 79
Hyperphagia in Bardet-Biedl syndrome: Pathophysiology, burden, and management 65
Obesity and Kidney Disease: A Focus on Ciliopathies 54
Correction: Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria(European Journal of Human Genetics, (2021), 29, 8, (1186-1197), 10.1038/s41431-021-00858-1) 53
Ravulizumab in treatment-naïve patients with atypical hemolytic uremic syndrome: a real-world case series 7
Totale 11.439
Categoria #
all - tutte 35.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.858


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021241 0 0 0 0 0 11 64 41 13 37 52 23
2021/2022576 30 9 5 18 184 16 13 18 15 68 39 161
2022/20231.075 92 52 18 80 127 63 4 57 531 12 22 17
2023/2024549 47 20 23 24 137 129 12 16 8 5 41 87
2024/20252.102 92 14 7 50 257 276 311 156 238 479 127 95
2025/20265.861 352 497 317 318 585 3.792 0 0 0 0 0 0
Totale 11.439